The short answer
Ask the prescriber before adding melatonin to temazepam. Melatonin product guidance cautions about benzodiazepine sedation, but direct temazepam combination evidence is limited.
What this answer covers
Oral melatonin; prolonged-release product guidance and immediate-release experimental doses are not identical.
- Supplement or preparation
- Melatonin
- Medication ingredient
- temazepam
Why adding a sleep aid needs review
The melatonin product information cautions that it can enhance sedative effects of benzodiazepines. Temazepam already affects alertness, so the prescriber should assess the actual product and reason for adding it.
What the comparison study showed
Melatonin and temazepam each shortened sleep onset in a daytime study, but they were not taken together. The result cannot quantify extra impairment from the combination.
Avoid inventing a safer schedule
The evidence does not establish a protective gap or a universally safe melatonin dose with temazepam. Tell the prescriber whether your product is immediate- or prolonged-release.
Protect your alertness
Temazepam can impair coordination and alertness. Avoid driving when affected. Seek urgent help for severe difficulty waking or breathing, and tell the prescriber about all other sedating medicines and alcohol.
Evidence and practical considerations
Side effects & toxicity
A conditional alertness precaution is supported by official melatonin guidance, not by treating separate-dose comparison as proof of additive sedation.
- Exact scope
- Oral melatonin; prolonged-release product guidance and immediate-release experimental doses are not identical. with Exact oral temazepam; no blanket benzodiazepine metabolic or route transfer.
- Medication form and route
- oral; other cannabis routes only if explicitly discussed
- Timing or duration
- Exact duration and dose depend on source; single-dose and chronic use are distinguished.
What remains uncertain
- No exact combination trial identified in this search. The direct temazepam/melatonin experiment compared treatments separately.
Factors that may matter: preparation and plant part; dose; other medicines; baseline alertness; clinical indication.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients prescribed oral temazepam.
CNS depression, impaired coordination and alertness can occur; concomitant CNS depressants require caution. Dependence and withdrawal risks require individualized tapering rather than abrupt cessation. Metabolized primarily through conjugation with no active metabolites; not an alprazolam CYP3A profile. Complex sleep behaviors can occur and CNS depressants may increase their risk.
How this applies: Exact RxNorm ingredient and oral formulation confirmed in original label; use exact indication and metabolic boundaries.
Does not quantify the requested botanical interaction risks, prove every herb is sedating, or establish a protective supplement interval.
Source 2: product label
medicines.org.uk · Source check Sep 10, 2026
Population: People considering the specified supplement.
Can cause drowsiness and impair driving. Bedtime instructions are specific to this prolonged-release preparation. Co-administration with zolpidem increased impairment, but that is a different medicine.
How this applies: Preparation-specific context; not a directly measured temazepam interaction.
No temazepam study. Findings with zolpidem or this licensed formulation cannot define every melatonin product or a protective interval.
Source 3: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Twenty young healthy adults.
Both active treatments shortened sleep onset latency and reduced core temperature versus placebo.
How this applies: Apply only to exact medication, preparation and study exposure; comparator treatment is not co-use.
Comparator trial, not combination. Similar individual effects cannot quantify additive impairment.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Current exact claims adjudicated against captured originals and explicit comparator/co-use boundaries. | |
| Research summary published |
Article revision: dbd55bc9849b28b3
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.